XPO1E571K Mutation Modifies Exportin 1 Localisation and Interactome in B-Cell Lymphoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
XPO1E571K Mutation Modifies Exportin 1 Localisation and Interactome in B-Cell Lymphoma
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 10, Pages 2829
Publisher
MDPI AG
Online
2020-09-30
DOI
10.3390/cancers12102829
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- XPO1-dependent nuclear export as a target for cancer therapy
- (2020) Nancy G. Azizian et al. Journal of Hematology & Oncology
- Targeting nuclear import and export in hematological malignancies
- (2020) Boaz Nachmias et al. LEUKEMIA
- Recognition of nuclear export signals by CRM1 carrying the oncogenic E571K mutation
- (2020) Jordan M. Baumhardt et al. MOLECULAR BIOLOGY OF THE CELL
- Histamine releasing factor and elongation factor 1 alpha secreted via malaria parasites extracellular vesicles promote immune evasion by inhibiting specific T cell responses
- (2019) Claudia Demarta-Gatsi et al. CELLULAR MICROBIOLOGY
- Altered nuclear export signal recognition as a driver of oncogenesis
- (2019) Justin Taylor et al. Cancer Discovery
- The LL-100 panel: 100 cell lines for blood cancer studies
- (2019) Hilmar Quentmeier et al. Scientific Reports
- STAT6 is a cargo of exportin 1: Biological relevance in primary mediastinal B-cell lymphoma
- (2018) Hadjer Miloudi et al. CELLULAR SIGNALLING
- New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genes
- (2018) Elsa Maitre et al. Oncotarget
- The PRIDE database and related tools and resources in 2019: improving support for quantification data
- (2018) Yasset Perez-Riverol et al. NUCLEIC ACIDS RESEARCH
- XPO1 in B cell hematological malignancies: from recurrent somatic mutations to targeted therapy
- (2017) Vincent Camus et al. Journal of Hematology & Oncology
- Gain in the short arm of chromosome 2 (2p+) induces gene overexpression and drug resistance in chronic lymphocytic leukemia: analysis of the central role of XPO1
- (2017) A Cosson et al. LEUKEMIA
- Cytoplasmic cyclin D1 controls the migration and invasiveness of mantle lymphoma cells
- (2017) Simon Body et al. Scientific Reports
- RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma
- (2016) Mingzhi Zhang et al. Aging-US
- Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma
- (2016) Fabrice Jardin et al. AMERICAN JOURNAL OF HEMATOLOGY
- Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target
- (2016) Michael T. Werner et al. BLOOD
- A cellular reporter to evaluate CRM1 nuclear export activity: functional analysis of the cancer-related mutant E571K
- (2016) Iraia García-Santisteban et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study
- (2016) S. Dubois et al. CLINICAL CANCER RESEARCH
- Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma
- (2016) V. Camus et al. HAEMATOLOGICA
- Structural Biology and Regulation of Protein Import into the Nucleus
- (2016) Mary Christie et al. JOURNAL OF MOLECULAR BIOLOGY
- CRISPR-Barcoding for Intratumor Genetic Heterogeneity Modeling and Functional Analysis of Oncogenic Driver Mutations
- (2016) Alexis Guernet et al. MOLECULAR CELL
- The RanBP2/RanGAP1*SUMO1/Ubc9 SUMO E3 ligase is a disassembly machine for Crm1-dependent nuclear export complexes
- (2016) Tobias Ritterhoff et al. Nature Communications
- Ran GTPase promotes cancer progression via Met receptor-mediated downstream signaling
- (2016) Hiu-Fung Yuen et al. Oncotarget
- Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma
- (2016) V. Camus et al. HAEMATOLOGICA
- A Human Interactome in Three Quantitative Dimensions Organized by Stoichiometries and Abundances
- (2015) Marco Y. Hein et al. CELL
- Importin β1 mediates nuclear factor-κB signal transduction into the nuclei of myeloma cells and affects their proliferation and apoptosis
- (2015) Wenqing Yan et al. CELLULAR SIGNALLING
- Identifying Drug-Target Selectivity of Small-Molecule CRM1/XPO1 Inhibitors by CRISPR/Cas9 Genome Editing
- (2015) Jasper E. Neggers et al. CHEMISTRY & BIOLOGY
- Upregulation of nuclear transporter, Kpnβ1, contributes to accelerated cell proliferation- and cell adhesion-mediated drug resistance (CAM-DR) in diffuse large B-cell lymphoma
- (2015) Song He et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Panorama of ancient metazoan macromolecular complexes
- (2015) Cuihong Wan et al. NATURE
- Gene essentiality and synthetic lethality in haploid human cells
- (2015) V. A. Blomen et al. SCIENCE
- Identification and characterization of essential genes in the human genome
- (2015) T. Wang et al. SCIENCE
- Structural and Functional Characterization of CRM1-Nup214 Interactions Reveals Multiple FG-Binding Sites Involved in Nuclear Export
- (2015) Sarah A. Port et al. Cell Reports
- A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning
- (2015) Koray Kırlı et al. eLife
- Genomic Landscape of Primary Mediastinal B-Cell Lymphoma Cell Lines
- (2015) Haiping Dai et al. PLoS One
- The mutational landscape of Hodgkin lymphoma cell lines determined by whole-exome sequencing
- (2014) Y Liu et al. LEUKEMIA
- Atomic basis of CRM1-cargo recognition, release and inhibition
- (2014) Ho Yee Joyce Fung et al. SEMINARS IN CANCER BIOLOGY
- Importazole, a Small Molecule Inhibitor of the Transport Receptor Importin-β
- (2011) Jonathan F. Soderholm et al. ACS Chemical Biology
- The molecular pathogenesis of primary mediastinal large B-cell lymphoma
- (2011) C. Steidl et al. BLOOD
- Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways
- (2011) H.-F. Yuen et al. CLINICAL CANCER RESEARCH
- Global enhancement of nuclear localization-dependent nuclear transport in transformed cells
- (2011) Henna V. Kuusisto et al. FASEB JOURNAL
- Ran-dependent docking of importin-β to RanBP2/Nup358 filaments is essential for protein import and cell viability
- (2011) Masakazu Hamada et al. JOURNAL OF CELL BIOLOGY
- Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
- (2011) Xose S. Puente et al. NATURE
- Oncogenic Activation of NF- B
- (2010) L. M. Staudt Cold Spring Harbor Perspectives in Biology
- Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma
- (2009) O. Ritz et al. BLOOD
- Structural basis for leucine-rich nuclear export signal recognition by CRM1
- (2009) Xiuhua Dong et al. NATURE
- Crystal Structure of the Nuclear Export Receptor CRM1 in Complex with Snurportin1 and RanGTP
- (2009) T. Monecke et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started